New hope for young brain tumor patients: chemotherapy first, then targeted radiation
NCT ID NCT00602667
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This clinical trial tests a risk-adapted approach for young children with newly diagnosed brain tumors. The treatment starts with chemotherapy to delay radiation, giving the brain more time to develop. Then, radiation is carefully targeted to the tumor area to reduce side effects on thinking and learning. The study includes children with several tumor types, such as medulloblastoma and high-grade glioma, and aims to improve survival while protecting brain function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- chemotherapy (methotrexate, vincristine, cisplatin, cyclophosphamide) and radiation therapy
- What this could lead to
- If successful, this approach could improve survival rates for young children with brain tumors while reducing long-term thinking and learning problems.
- What could go wrong
- This is a Phase 2 trial, so results are still preliminary. The combination of chemotherapy and radiation may still cause side effects, and not all tumor types may respond equally.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATYPICAL TERATOID/RHABDOID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Children's Hospitals and Clinics of Minnesota - St. Paul
Saint Paul, Minnesota, 55102, United States
-
Lady Cilento Children's Hospital, Brisbane
Brisbane, Queensland, 4029, Australia
-
Lucile Packard Children's Hospital at Stanford University Medical Center
Palo Alto, California, 94304, United States
-
Rady Children's Hospital
San Diego, California, 92123, United States
-
St. Jude Children's Research Hospital
Memphis, Tennessee, 38105, United States
-
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can trained immune cells outsmart brain tumors?
- Can the Body's own immune cells beat a recurrent brain tumor?
- Could cutting a wider margin around brain tumors extend survival?
- Can a Tumor's genetic blueprint guide better treatment for kids with brain cancer?
- Can a new tracer light up cancer growth?
- Can a 7-Week brain tumor treatment beat the standard 10-Week plan?